SCI Faculty members develop standardized infusion protocols used to deliver FDA-approved cell therapies

SCI Faculty members, Allison Hubel, PhD and David McKenna Jr., MD conducted a study to develop standardized infusion protocols used to deliver the growing number of FDA-approved cell therapies.  They observed infusions at three academic medical centers in the United States, and then analyzed and compared the workflows.  This analysis identified opportunities to standardize and streamline the infusion workflow which may help facilitate adoption of new and existing cell therapies at a wider range of hospitals. Read the paper.

 

Share this post

Related News